eight:normal;font-style:normal;text-transform:none;font-variant:

normal;"> 

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

Form 8-K
 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported):   December 12, 2019
 
Dynavax Technologies Corporation

(Exact name of registrant as specified in its charter)

 

Commission File Number:  001-34207

 
Delaware

   
33-0728374
 Share
        

                                            © Acquiremedia - 2019